Publication | Open Access
CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer
21
Citations
23
References
2017
Year
CMTM1_v17 expression is significantly associated with chemoresistance and poor prognosis of the early stage NSCLC patients who have received NAC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1